Since the Food and Drug Administration published its final rule in April on regulating laboratory developed tests (LDTs), the agency has been swamped with questions about how it plans to move forward and what the new regulations mean for industry and patients.
In response, the FDA has created a webpage based on the “most common questions” it has received related to...